Last update:
Oncology & Cancer news
Oncology & Cancer
'Fast-fail' AI blood test could steer patients with pancreatic cancer away from ineffective therapies
An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood, developed by Johns Hopkins Kimmel Cancer Center investigators, could help clinicians more quickly identify ...
7 hours ago
0
0
Oncology & Cancer
Genomic score predicts patients' progression to multiple myeloma
A new risk assessment score developed by researchers at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, and Massachusetts General Hospital reveals how multiple myeloma, a form of blood cancer, begins ...
7 hours ago
0
0
Common antidepressants could help the immune system fight cancer
A widely used antidepressant drug could help the immune system fight cancer, according to a new UCLA research study.
8 hours ago
0
54
Small molecules in plant-based foods may reduce efficacy of anti-cancer drugs
A Ludwig Cancer Research study has uncovered a surprising link between diet, intestinal microbes and the efficacy of cancer therapy.
7 hours ago
0
19
Lethal mutations cause 1 in 136 in pregnancy losses, study estimates
In a study published in Nature today "Sequence diversity lost in early pregnancy," scientists from deCODE genetics, estimate that around one in 136 pregnancies are lost due to new mutations in the fetus. In other words, millions ...
8 hours ago
0
0
Oxygen deficiency within tumors can indirectly promote colon cancer growth
To effectively battle cancer, scientists must study the battlefield. Now, in a recent study published in Nature Communications, a multi-institutional research team including The University of Osaka has discovered some crucial ...
10 hours ago
0
29
Molecular process driving deadly childhood brain cancer discovered
An international group of scientists has identified a key molecular process that drives a deadly form of childhood brain cancer, potentially offering a much-needed, new therapeutic target.
10 hours ago
0
25
Similar survival seen with simple versus radical hysterectomy for cervical cancer
For patients with low-risk cervical cancer, survival is similar following simple hysterectomy (SH) versus modified radical hysterectomy (MRH) or radical hysterectomy (RH), according to a study published online May 15 in JAMA ...
6 hours ago
0
0
Promising results of niraparib appear in patients with advanced melanoma
Researchers at Sutter's California Pacific Medical Center (CPMC) in San Francisco, Calif. have discovered early signs of clinical benefit while testing niraparib, a PARP inhibitor, in patients with advanced melanoma whose ...
7 hours ago
0
0
Biden is getting prostate cancer treatment, but that's not the best choice for all men
"Me encontraron càncer en la pròstata," my father told me. "They found cancer in my prostate."
11 hours ago
0
0
Tumor-related epilepsy not a strong prognostic factor in diffuse glioma, finds study
For patients with diffuse gliomas, tumor-related epilepsy (TRE) is not a strong prognostic factor, according to a study published in the May issue of Brain and Behavior.
5 hours ago
0
0
Gene mutations and cell maturity identified as key factors in acute myeloid leukemia treatment resistance
An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn't work for everyone. The findings could help doctors better match patients ...
12 hours ago
0
0
FDA approves Zynyz as first-line treatment for advanced anal cancer
The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first first-line treatment for advanced anal cancer.
5 hours ago
0
0
Beyond tired with cancer-related fatigue
Cancer-related fatigue can be distressing. It is a persistent, subjective sense of physical, emotional and cognitive tiredness and/or exhaustion related to cancer or cancer treatment that is not proportional to recent activity. ...
16 hours ago
0
0
T cell cytokines found to influence tumor-immune interactions in metastases
Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a dendritic-cell–natural-killer-cell circuit that suppresses leptomeningeal metastases in mouse models.
Gut microbes may help protect patients from chemotherapy side effects
Chemotherapy doesn't just kill cancer cells. It also affects the microbes in the digestive tract. Researchers at UC San Francisco have discovered that some gut bacteria can reduce the side effects of these potent treatments, ...
May 20, 2025
0
71
Genomic testing aids precision therapy and tissue of origin identification for cancers whose primary site is unknown
A new study highlights the potential of whole genome and transcriptome sequencing (WGTS) to improve precision treatment and identify the tissue of origin for cancers whose primary site is unknown, also called cancers of unknown ...
May 20, 2025
0
0
Ethnic differences in breast cancer development and outcomes highlight need for tailored care approaches
Women of African or South Asian genetic ancestry tend to develop breast cancer and die at a younger age than women of European ancestry, according to new research by Queen Mary University of London. The study, which looked ...
May 20, 2025
0
22
Scientists develop new treatment with potential to tackle most common form of childhood cancer
A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukemia (B-ALL), the most common cancer in childhood and one that can be particularly difficult ...
May 20, 2025
0
2
Genetic test can diagnose brain tumors in as little as two hours
Scientists and medics have developed an ultra-rapid method of genetically diagnosing brain tumors that will cut the time it takes to classify them from six to eight weeks, to as little as two hours—which could improve care ...
May 20, 2025
0
1
'Obesity paradox' extends to cancer treatment, study finds
It's well-known that obesity is a risk factor for cardiovascular disease. But some research suggests that while people who are obese are more likely to develop cardiovascular problems, they're also less likely to die from ...
May 20, 2025
0
0
Mitochondrial protein may improve selective liver cancer treatment
Hepatocarcinoma is the most commonly diagnosed form of liver cancer. It is an aggressive, fast growing cancer with a 5-year survival rate of only 15%. Thomas Jefferson University researcher Gyorgy Hajnoczky, MD/Ph.D., and ...
May 20, 2025
0
0
Liver cancer cells under pressure: Compression can spark invasion, drug resistance and altered gene activity
Yale researchers are providing new insights into how physical forces, such as cells being compressed in physically restrictive environments, play key roles in cancer progression.
May 20, 2025
0
0
Liquid biopsy blood test shows superior sensitivity in detecting HPV-associated head and neck cancers
A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with significantly higher accuracy than currently used methods, including before patients develop symptoms, ...
May 20, 2025
0
0
CAR-T cell therapy is revolutionizing cancer treatment. Here's how it works
Personalized medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools. This innovative approach, which involves genetically modifying the cells of the immune system, is ...
May 20, 2025
0
0
